Edition:
United Kingdom

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

30.40USD
23 May 2018
Change (% chg)

$0.56 (+1.88%)
Prev Close
$29.84
Open
$29.61
Day's High
$31.20
Day's Low
$29.15
Volume
40,956
Avg. Vol
26,372
52-wk High
$33.80
52-wk Low
$16.89

Latest Key Developments (Source: Significant Developments)

WuXi NextCODE Entered Partnership With Rhythm Pharmaceuticals Financial
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - WuXi NextCODE: :WUXI NEXTCODE - ENTERED PARTNERSHIP WITH RHYTHM PHARMACEUTICALS; FINANCIAL TERMS WERE NOT DISCLOSED.  Full Article

Rhythm Pharmaceuticals Announces Progress In Clinical Development Of Setmelanotide
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Rhythm Pharmaceuticals Inc ::RHYTHM PHARMACEUTICALS ANNOUNCES PROGRESS IN CLINICAL DEVELOPMENT OF SETMELANOTIDE FOR TREATMENT OF RARE GENETIC DISORDERS OF OBESITY.RHYTHM PHARMACEUTICALS - SETMELANOTIDE GRANTED ORPHAN DRUG DESIGNATION FOR TREATMENT OF LEPTIN RECEPTOR (LEPR) DEFICIENCY OBESITY.RHYTHM PHARMACEUTICALS - FINALIZED PROTOCOL FOR PIVOTAL PHASE 3 CLINICAL TRIAL IN PRO-OPIOMELANOCORTIN (POMC) DEFICIENCY OBESITY.RHYTHM PHARMACEUTICALS - CONFIRMS PLANS TO FILE NDA WITH FDA BASED ON ONE-YEAR DATA FROM 10 PATIENT COHORT IN POMC PHASE 3 CLINICAL TRIAL.  Full Article

Rhythm Pharmaceuticals reports Q3 loss of $1.78/shr
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Rhythm Pharmaceuticals Inc :Rhythm Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $1.78.Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Rhythm Pharmaceuticals Inc - ‍as of Sept 30, cash, cash equivalents, short-term investments were $30.4 million, as compared to $10.5 million as of Dec 31, 2016​.  Full Article

‍Orbimed Advisors reports 10.7 pct stake in Rhythm Pharmaceuticals ​
Friday, 20 Oct 2017 

Oct 20 (Reuters) - Rhythm Pharmaceuticals Inc ::‍orbimed Advisors reports a 10.7 percent stake in Rhythm Pharmaceuticals Inc as of october 10 - sec filing​.  Full Article

Pfizer reports 5.4 pct passive stake in Rhythm Pharmaceuticals - ‍​SEC filing
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Pfizer Inc ::Pfizer Inc reports 5.4 percent passive stake in Rhythm Pharmaceuticals Inc as of October 10, 2017 - ‍​SEC filing.  Full Article

New Enterprise Associates 13 reports 18.8 percent stake in Rhythm Pharma as of Oct 10
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Rhythm Pharmaceuticals Inc :New Enterprise Associates 13 L.P. reports a 18.8 percent stake in Rhythm Pharmaceuticals Inc as of October 10, 2017 - SEC Filing‍​.  Full Article

Rhythm Pharmaceuticals shares open at $23.21 in debut vs IPO price of $17
Thursday, 5 Oct 2017 

Oct 5 (Reuters) - Rhythm Pharmaceuticals Inc :Rhythm pharmaceuticals inc shares open at $23.21 in debut on nasdaq versus IPO price of $17.00 per share.  Full Article

BRIEF-Rhythm Pharma Announces Licensing Agreement With Takeda

* RHYTHM PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH TAKEDA FOR THE DEVELOPMENT AND COMMERCIALIZATION OF PRECLINICAL TREATMENT FOR PRADER-WILLI SYNDROME